An Australian guideline on the diagnosis of overseas-acquired Lyme disease/borreliosis
DOI:
https://doi.org/10.33321/cdi.2015.39.53Keywords:
Lyme disease, diagnostic testing, guidelinesAbstract
The Australian Department of Health, with assistance from the Lyme disease Diagnostic Pathway Working Group, has recently developed An Australian guideline on the diagnosis of overseas acquired Lyme Disease/Borreliosis. The document is a diagnostic clinical aid for medical practitioners in Australia who are unfamiliar with Lyme disease acquired overseas.
Downloads
References
Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011;17(1):69–79.
Ciceroni L, Ciarrochi S, Ciervo A, Mondarini V, Guzzo F, Caruso G, et al. Isolation and characterization of Borrelia burgdorferi sensu lato strains in an area of Italy where Lyme borreliosis is endemic. J Clin Microbiol 2001;39(6):2254–2260.
Aguero-Rosenfeld ME. Lyme disease: laboratory issues. Infect Dis Clin North Am 2008;22(2):301–313.
Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007;49(1):13–21.
Stanek G, Klein J, Bittner R, Glogar D. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990;322(4):249–252.
van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993;17(4):708–717.
Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18(3):484–509.
Pfister HW, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994;343(8904):1013–1016.
Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002;136(6):421–428.
Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996;108(23):741–747.
Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999;130(1):32–36.
Wetter DA, Ruff CA. Erythema migrans in Lyme disease. Can Med Assoc J 2011;183(11):1281–1281.
Mygland Å, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010;17(1):8–16, e1–e4.
Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998;352(9127):557–565.
Krupp LB, Masur D, Schwartz J, Coyle PK, Langenbach LJ, Fernquist SK, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol 1991;48(11):1125–1129.
Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Inter J Epidemiol 2005;34(6):1340–1345.
Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurol 2003;60(12):1916–1922.
Downloads
Published
How to Cite
License
Copyright (c) 2015 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
